Infinity Pharmaceuticals, Inc.

Intellikine LLC

Innovative Signal Analysis, Inc.

Sigma-aldrich Co. LLC

Michael Martin

Pingda Ren

Yi Liu

Liansheng Li

Troy Edward Wilson

Katrina Chan

Paul Isbester

Benjamin S Lane

Jason Kropp

Christian Rommel

Lynne Bui

Daniel P Gibbs

Stacy Kniffen

Rachel A Rivera

Robert Mingee

Blake Levy

Susanna Del Rio Gancedo

Jonathan Edward Ray

Adam Earl Scott

Joseph Evan Harris

Thomas Nicholas Zogakis

Julia Florence Kerst

An object detection system includes a first camera having a first field of view and a second camera having a second field of view that overlaps with the first field of view. The object detection system includes object detection logic configured to receive a first image from the first camera and a second image from the second camera and identify an object in both the first and second image. The object detection system further includes object mapping logic configured to identify a location of the object based on the first and second image. The object detection system also includes display logic configured to display the location of the object.

Multi-source 3-dimensional detection and tracking

Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including P13 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof.

Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one

A system for providing a geographical location for a detected moving object is presented. The system comprises a camera configured to capture a first image of a field of view at a first time, and a second image of a field of view at a second time. The field of view includes a moving object. The system also comprises a processor configured to receive the first and second images of the field of view, index the first and second images based on an associated timestamp, and provide the first and second images to a nonvolatile storage medium. The system also comprises a change detection module configured to compare the first and second images and detect the moving object. The system also comprises a position identification module configured to calculate and provide the geographical location for the detected moving object, based on a known location of the camera, and a calibration of the field of view. The system also comprises a display, configured to receive an updated display feed from the processor. The updated display feed comprises the second image, an indication of the detected moving object, and an indication of a location of the detected moving object.

Target detection and mapping using an image acqusition device

Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including Pl3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof.

Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one and methods of use thereof

Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof.

Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one and methods of use thereof

Processes for preparing isoquinolinones and solid forms of isoquinolinones

The present invention provides for methods and pharmaceutical compositions comprising inhibitors of mTorC1 and/or mTorC2. In some aspects, the invention provides for treatment regimens resulting in enhanced treatment efficacy and better tolerability.

Enhanced treatment regimens using mTOR inhibitors

Polymorphs of chemical compounds that modulate kinase activity, including PI3K activity, and chemical compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3K activity, are described herein.

Kinase inhibitor polymorphs

Enhanced treatment regimens using mTor inhibitors

Growing community of inventors

San Marcos, CA, United States of America

Michael Martin